| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 37 | 2025 | 3912 | 2.220 |
Why?
|
| Delirium | 19 | 2025 | 1697 | 1.810 |
Why?
|
| Proto-Oncogene Proteins c-ets | 25 | 2016 | 313 | 1.520 |
Why?
|
| Proteome | 17 | 2024 | 1890 | 1.390 |
Why?
|
| Blood Proteins | 9 | 2024 | 1191 | 1.340 |
Why?
|
| Proto-Oncogene Proteins | 25 | 2023 | 4528 | 1.270 |
Why?
|
| NF-kappa B | 21 | 2015 | 2493 | 1.060 |
Why?
|
| Nasal Polyps | 9 | 2020 | 412 | 0.970 |
Why?
|
| Transcription Factors | 37 | 2014 | 12168 | 0.930 |
Why?
|
| Rhinitis | 9 | 2020 | 753 | 0.820 |
Why?
|
| Relaxation Therapy | 2 | 2018 | 181 | 0.820 |
Why?
|
| DNA-Binding Proteins | 31 | 2011 | 9615 | 0.750 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 13 | 2023 | 2892 | 0.710 |
Why?
|
| C-Reactive Protein | 8 | 2024 | 3858 | 0.690 |
Why?
|
| Gene Expression Regulation, Neoplastic | 24 | 2016 | 8647 | 0.680 |
Why?
|
| Nuclear Proteins | 22 | 2016 | 5804 | 0.680 |
Why?
|
| Postoperative Complications | 17 | 2025 | 15832 | 0.680 |
Why?
|
| Sinusitis | 8 | 2020 | 997 | 0.660 |
Why?
|
| Proto-Oncogene Proteins c-jun | 4 | 2011 | 287 | 0.630 |
Why?
|
| Exosomes | 6 | 2022 | 422 | 0.630 |
Why?
|
| Apoptosis | 24 | 2024 | 9523 | 0.610 |
Why?
|
| Interleukin-6 | 11 | 2024 | 3228 | 0.600 |
Why?
|
| Gene Expression Profiling | 35 | 2022 | 9538 | 0.580 |
Why?
|
| Relaxation | 2 | 2018 | 51 | 0.570 |
Why?
|
| Cell Cycle Proteins | 8 | 2016 | 3445 | 0.550 |
Why?
|
| Carcinoma, Renal Cell | 8 | 2014 | 3187 | 0.550 |
Why?
|
| Pre-Eclampsia | 4 | 2022 | 1255 | 0.540 |
Why?
|
| Gene Expression Regulation | 28 | 2018 | 11928 | 0.510 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 11 | 2024 | 3814 | 0.490 |
Why?
|
| Heart Arrest, Induced | 4 | 2012 | 359 | 0.480 |
Why?
|
| Transcriptional Activation | 15 | 2007 | 1750 | 0.470 |
Why?
|
| Pentamidine | 1 | 2014 | 44 | 0.460 |
Why?
|
| Adenoviridae | 6 | 2005 | 1092 | 0.450 |
Why?
|
| Promoter Regions, Genetic | 30 | 2011 | 5797 | 0.430 |
Why?
|
| Transcription, Genetic | 26 | 2012 | 7608 | 0.430 |
Why?
|
| Prostatic Neoplasms | 13 | 2023 | 11101 | 0.420 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 24 | 2015 | 3800 | 0.420 |
Why?
|
| Case-Control Studies | 18 | 2024 | 22291 | 0.400 |
Why?
|
| Up-Regulation | 19 | 2022 | 4146 | 0.400 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 6 | 2009 | 505 | 0.380 |
Why?
|
| Base Sequence | 26 | 2012 | 12421 | 0.370 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 20 | 2011 | 4580 | 0.370 |
Why?
|
| Molecular Sequence Data | 30 | 2012 | 17622 | 0.370 |
Why?
|
| Cerebrospinal Fluid Proteins | 2 | 2023 | 71 | 0.370 |
Why?
|
| Humans | 199 | 2025 | 768166 | 0.370 |
Why?
|
| Trans-Activators | 10 | 2012 | 2857 | 0.360 |
Why?
|
| Serine Endopeptidases | 1 | 2016 | 1027 | 0.360 |
Why?
|
| Endometriosis | 3 | 2024 | 873 | 0.360 |
Why?
|
| Exocrine Glands | 1 | 2010 | 46 | 0.360 |
Why?
|
| Inflammation | 20 | 2024 | 10873 | 0.360 |
Why?
|
| Pyloric Antrum | 1 | 2010 | 66 | 0.350 |
Why?
|
| Mucus | 2 | 2018 | 346 | 0.340 |
Why?
|
| Meditation | 1 | 2013 | 257 | 0.330 |
Why?
|
| Mitochondrial Proteins | 3 | 2009 | 979 | 0.330 |
Why?
|
| Kidney Neoplasms | 6 | 2011 | 4282 | 0.330 |
Why?
|
| MAP Kinase Kinase 4 | 3 | 2011 | 147 | 0.330 |
Why?
|
| Yoga | 1 | 2013 | 280 | 0.320 |
Why?
|
| B-Lymphocytes | 8 | 2014 | 4793 | 0.320 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2024 | 2333 | 0.310 |
Why?
|
| Membrane Proteins | 11 | 2016 | 7876 | 0.310 |
Why?
|
| Cell Line | 31 | 2012 | 15597 | 0.300 |
Why?
|
| Aptamers, Nucleotide | 2 | 2019 | 163 | 0.290 |
Why?
|
| Lipopolysaccharides | 6 | 2022 | 2219 | 0.290 |
Why?
|
| Sequence Homology, Amino Acid | 11 | 2012 | 2748 | 0.290 |
Why?
|
| Aged | 48 | 2025 | 171504 | 0.290 |
Why?
|
| Islets of Langerhans Transplantation | 4 | 2012 | 748 | 0.290 |
Why?
|
| Cell Line, Tumor | 25 | 2020 | 17140 | 0.290 |
Why?
|
| Interleukin-1 | 6 | 2003 | 1252 | 0.290 |
Why?
|
| Chemokines, CXC | 2 | 2007 | 420 | 0.280 |
Why?
|
| Male | 86 | 2025 | 364719 | 0.280 |
Why?
|
| Signal Transduction | 29 | 2019 | 23645 | 0.270 |
Why?
|
| Immunoglobulin Heavy Chains | 3 | 1996 | 648 | 0.270 |
Why?
|
| Cullin Proteins | 2 | 2023 | 180 | 0.270 |
Why?
|
| Female | 82 | 2025 | 397192 | 0.270 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2012 | 2271 | 0.260 |
Why?
|
| Albuminuria | 1 | 2010 | 658 | 0.260 |
Why?
|
| Interleukins | 2 | 2011 | 796 | 0.260 |
Why?
|
| RNA, Messenger | 23 | 2019 | 12800 | 0.260 |
Why?
|
| Protein Array Analysis | 3 | 2012 | 399 | 0.250 |
Why?
|
| Down-Regulation | 8 | 2022 | 2937 | 0.250 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 3 | 2022 | 560 | 0.250 |
Why?
|
| Liver Neoplasms | 4 | 2024 | 4362 | 0.240 |
Why?
|
| Energy Metabolism | 3 | 2013 | 2907 | 0.240 |
Why?
|
| Animals | 85 | 2023 | 169246 | 0.240 |
Why?
|
| Chondrocytes | 5 | 2010 | 800 | 0.240 |
Why?
|
| Cell Differentiation | 15 | 2021 | 11669 | 0.240 |
Why?
|
| Oligonucleotides | 3 | 2023 | 563 | 0.240 |
Why?
|
| Myelodysplastic Syndromes | 4 | 2009 | 1399 | 0.240 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2016 | 1757 | 0.240 |
Why?
|
| Genes | 6 | 2010 | 1824 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2007 | 580 | 0.240 |
Why?
|
| Enzyme Induction | 1 | 2005 | 455 | 0.230 |
Why?
|
| Antineoplastic Agents | 16 | 2015 | 13676 | 0.230 |
Why?
|
| Pelvic Pain | 2 | 2024 | 300 | 0.230 |
Why?
|
| Mice | 57 | 2023 | 82029 | 0.230 |
Why?
|
| Blotting, Western | 9 | 2015 | 5027 | 0.230 |
Why?
|
| Sulindac | 3 | 2011 | 29 | 0.230 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 319 | 0.230 |
Why?
|
| Religion | 2 | 2021 | 376 | 0.230 |
Why?
|
| Blood-Brain Barrier | 2 | 2021 | 1034 | 0.220 |
Why?
|
| Genetic Vectors | 6 | 2004 | 3402 | 0.220 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2011 | 3611 | 0.220 |
Why?
|
| Amino Acid Sequence | 18 | 2012 | 13421 | 0.220 |
Why?
|
| Neoplasm Proteins | 4 | 2015 | 3603 | 0.220 |
Why?
|
| Eosinophils | 2 | 2018 | 952 | 0.210 |
Why?
|
| src-Family Kinases | 2 | 2004 | 539 | 0.210 |
Why?
|
| Adenocarcinoma | 3 | 2016 | 6395 | 0.210 |
Why?
|
| Genes, p53 | 1 | 2005 | 714 | 0.210 |
Why?
|
| Inflammation Mediators | 4 | 2024 | 1892 | 0.210 |
Why?
|
| Osteoblasts | 3 | 2018 | 1145 | 0.210 |
Why?
|
| Enhancer Elements, Genetic | 3 | 1996 | 1367 | 0.210 |
Why?
|
| Ovarian Neoplasms | 5 | 2012 | 4916 | 0.210 |
Why?
|
| Blood Pressure | 2 | 2018 | 8543 | 0.200 |
Why?
|
| Transfection | 13 | 2008 | 5755 | 0.200 |
Why?
|
| Receptors, Cell Surface | 16 | 2006 | 2819 | 0.200 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2012 | 4352 | 0.200 |
Why?
|
| Raynaud Disease | 1 | 2022 | 81 | 0.200 |
Why?
|
| Binding Sites | 15 | 2014 | 6020 | 0.200 |
Why?
|
| Cloning, Molecular | 10 | 2002 | 4168 | 0.200 |
Why?
|
| Cell Division | 5 | 2006 | 4473 | 0.190 |
Why?
|
| alpha 1-Antitrypsin | 3 | 2012 | 169 | 0.190 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 7 | 2010 | 792 | 0.190 |
Why?
|
| Nephrotic Syndrome | 2 | 2021 | 381 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 2 | 2011 | 71 | 0.190 |
Why?
|
| Computational Biology | 5 | 2023 | 3568 | 0.190 |
Why?
|
| Neutrophil Activation | 2 | 2019 | 180 | 0.190 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 5 | 2015 | 1627 | 0.190 |
Why?
|
| Carrier Proteins | 4 | 2014 | 4937 | 0.180 |
Why?
|
| Gene Targeting | 2 | 2006 | 841 | 0.180 |
Why?
|
| Gene Expression | 13 | 2014 | 7598 | 0.180 |
Why?
|
| Pulmonary Atelectasis | 1 | 2022 | 160 | 0.180 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2024 | 205 | 0.180 |
Why?
|
| Interleukin-2 | 1 | 2007 | 1895 | 0.180 |
Why?
|
| Gene Regulatory Networks | 5 | 2018 | 1752 | 0.180 |
Why?
|
| Insulin | 4 | 2013 | 6607 | 0.180 |
Why?
|
| Liver | 8 | 2012 | 7577 | 0.180 |
Why?
|
| Microarray Analysis | 3 | 2014 | 753 | 0.180 |
Why?
|
| Ischemia | 1 | 2009 | 1900 | 0.170 |
Why?
|
| Receptor, TIE-2 | 4 | 2018 | 183 | 0.170 |
Why?
|
| Endothelium, Vascular | 7 | 2019 | 4427 | 0.170 |
Why?
|
| Adult | 44 | 2024 | 223646 | 0.170 |
Why?
|
| Cytokines | 6 | 2021 | 7453 | 0.170 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2019 | 638 | 0.170 |
Why?
|
| Middle Aged | 41 | 2025 | 223492 | 0.170 |
Why?
|
| Hyperinsulinism | 1 | 2023 | 402 | 0.170 |
Why?
|
| Synovial Membrane | 1 | 2003 | 536 | 0.170 |
Why?
|
| Monocytes | 4 | 2019 | 2605 | 0.170 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2025 | 3683 | 0.170 |
Why?
|
| Oligonucleotide Probes | 5 | 2003 | 417 | 0.170 |
Why?
|
| Fanconi Anemia | 1 | 2022 | 327 | 0.170 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 4 | 2011 | 440 | 0.170 |
Why?
|
| Hematopoietic Stem Cells | 5 | 2019 | 3409 | 0.160 |
Why?
|
| Keratinocytes | 3 | 2000 | 876 | 0.160 |
Why?
|
| Capillary Leak Syndrome | 1 | 2019 | 34 | 0.160 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2020 | 188 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2020 | 748 | 0.160 |
Why?
|
| Fatty Acids | 3 | 2020 | 1812 | 0.160 |
Why?
|
| Astrocytes | 3 | 2020 | 1350 | 0.160 |
Why?
|
| Bone Morphogenetic Proteins | 4 | 2018 | 845 | 0.160 |
Why?
|
| Hypertension | 2 | 2018 | 8616 | 0.160 |
Why?
|
| Salivary Cystatins | 1 | 2018 | 11 | 0.160 |
Why?
|
| Osteitis | 1 | 2018 | 33 | 0.160 |
Why?
|
| Complement C7 | 1 | 2018 | 16 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 6 | 2019 | 1996 | 0.160 |
Why?
|
| Atrophy | 1 | 2024 | 1646 | 0.160 |
Why?
|
| Genome, Human | 3 | 2010 | 4446 | 0.160 |
Why?
|
| Scleroderma, Systemic | 1 | 2022 | 346 | 0.160 |
Why?
|
| Receptors, Complement 3d | 2 | 2014 | 117 | 0.160 |
Why?
|
| Peroxiredoxins | 1 | 2018 | 51 | 0.160 |
Why?
|
| Prospective Studies | 16 | 2025 | 54926 | 0.160 |
Why?
|
| Nasal Mucosa | 2 | 2019 | 416 | 0.150 |
Why?
|
| DNA, Complementary | 5 | 2009 | 1989 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 12 | 2016 | 6124 | 0.150 |
Why?
|
| Adenosine Triphosphatases | 3 | 2008 | 842 | 0.150 |
Why?
|
| Diet, Gluten-Free | 1 | 2021 | 284 | 0.150 |
Why?
|
| Predictive Value of Tests | 8 | 2025 | 15454 | 0.150 |
Why?
|
| Acute Lung Injury | 1 | 2022 | 377 | 0.150 |
Why?
|
| Fatty Liver | 1 | 2024 | 809 | 0.150 |
Why?
|
| Proteinuria | 3 | 2007 | 611 | 0.150 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2000 | 301 | 0.150 |
Why?
|
| Ileum | 1 | 2020 | 558 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 5446 | 0.150 |
Why?
|
| Neurofilament Proteins | 1 | 2020 | 336 | 0.150 |
Why?
|
| Shock, Cardiogenic | 1 | 2024 | 711 | 0.150 |
Why?
|
| Immunoglobulin G | 1 | 2010 | 4568 | 0.150 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2018 | 139 | 0.150 |
Why?
|
| Esophagus | 1 | 2024 | 1042 | 0.150 |
Why?
|
| Transplantation | 1 | 2019 | 221 | 0.150 |
Why?
|
| Immunoprecipitation | 4 | 2009 | 874 | 0.150 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 355 | 0.150 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2018 | 283 | 0.150 |
Why?
|
| Dairy Products | 1 | 2021 | 490 | 0.150 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2020 | 314 | 0.150 |
Why?
|
| Mice, Nude | 5 | 2020 | 3623 | 0.140 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2019 | 174 | 0.140 |
Why?
|
| Epistasis, Genetic | 1 | 2020 | 353 | 0.140 |
Why?
|
| Neutrophils | 3 | 2019 | 3786 | 0.140 |
Why?
|
| Mice, SCID | 6 | 2015 | 2627 | 0.140 |
Why?
|
| Neoplasms, Glandular and Epithelial | 3 | 2007 | 489 | 0.140 |
Why?
|
| Specimen Handling | 1 | 2022 | 708 | 0.140 |
Why?
|
| Liver Regeneration | 2 | 2011 | 214 | 0.140 |
Why?
|
| Metabolomics | 2 | 2024 | 1674 | 0.140 |
Why?
|
| Viral Matrix Proteins | 2 | 2013 | 193 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2022 | 3514 | 0.140 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2018 | 187 | 0.140 |
Why?
|
| Antigens, CD34 | 5 | 2019 | 657 | 0.140 |
Why?
|
| Cluster Analysis | 7 | 2020 | 2732 | 0.140 |
Why?
|
| Orthopedic Procedures | 3 | 2022 | 1279 | 0.140 |
Why?
|
| Valproic Acid | 2 | 2010 | 444 | 0.140 |
Why?
|
| RNA, Small Interfering | 5 | 2011 | 3428 | 0.140 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2020 | 327 | 0.140 |
Why?
|
| Diabetic Nephropathies | 2 | 2018 | 973 | 0.140 |
Why?
|
| Organ Specificity | 5 | 2010 | 1968 | 0.130 |
Why?
|
| Graft Rejection | 3 | 2019 | 4492 | 0.130 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2018 | 251 | 0.130 |
Why?
|
| Cyclin D3 | 1 | 2016 | 54 | 0.130 |
Why?
|
| 5'-Nucleotidase | 2 | 2008 | 164 | 0.130 |
Why?
|
| Cells, Cultured | 22 | 2010 | 19015 | 0.130 |
Why?
|
| Placenta Accreta | 1 | 2020 | 242 | 0.130 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2009 | 1151 | 0.130 |
Why?
|
| Phosphorylation | 13 | 2019 | 8317 | 0.130 |
Why?
|
| Aged, 80 and over | 17 | 2025 | 59629 | 0.130 |
Why?
|
| Antigens, Differentiation | 2 | 2010 | 921 | 0.130 |
Why?
|
| Facial Transplantation | 1 | 2018 | 220 | 0.130 |
Why?
|
| Protein Binding | 8 | 2013 | 9343 | 0.130 |
Why?
|
| Cell Cycle | 4 | 2015 | 2932 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2005 | 1169 | 0.130 |
Why?
|
| RNA Interference | 4 | 2011 | 2832 | 0.120 |
Why?
|
| Myocardium | 6 | 2012 | 4788 | 0.120 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2012 | 2846 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1997 | 640 | 0.120 |
Why?
|
| Enzyme Activation | 4 | 2011 | 3590 | 0.120 |
Why?
|
| Antigens, Nuclear | 2 | 2007 | 183 | 0.120 |
Why?
|
| Bacterial Typing Techniques | 1 | 2016 | 263 | 0.120 |
Why?
|
| Blood Coagulation Disorders | 1 | 2018 | 350 | 0.120 |
Why?
|
| Reproducibility of Results | 11 | 2022 | 20227 | 0.120 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 15662 | 0.120 |
Why?
|
| Multigene Family | 5 | 2007 | 1081 | 0.120 |
Why?
|
| Chemokines | 1 | 1999 | 963 | 0.120 |
Why?
|
| Phenylurea Compounds | 2 | 2015 | 531 | 0.120 |
Why?
|
| Prostaglandins E | 1 | 1994 | 166 | 0.120 |
Why?
|
| Metformin | 1 | 2022 | 909 | 0.120 |
Why?
|
| Capsid | 3 | 2002 | 435 | 0.120 |
Why?
|
| Hemodynamics | 2 | 2024 | 4194 | 0.120 |
Why?
|
| Serum Response Factor | 1 | 2014 | 78 | 0.110 |
Why?
|
| Nose | 1 | 2018 | 522 | 0.110 |
Why?
|
| Genomics | 4 | 2023 | 5926 | 0.110 |
Why?
|
| Endothelial Cells | 5 | 2019 | 3589 | 0.110 |
Why?
|
| Cytoplasm | 3 | 2009 | 1505 | 0.110 |
Why?
|
| Mutation | 14 | 2020 | 30238 | 0.110 |
Why?
|
| Virus Attachment | 1 | 2014 | 56 | 0.110 |
Why?
|
| Cell Survival | 7 | 2012 | 5777 | 0.110 |
Why?
|
| Focal Adhesions | 1 | 2014 | 113 | 0.110 |
Why?
|
| Apolipoproteins E | 1 | 2020 | 1461 | 0.110 |
Why?
|
| Cohort Studies | 7 | 2024 | 41754 | 0.110 |
Why?
|
| DNA Primers | 5 | 2005 | 2828 | 0.110 |
Why?
|
| Chronic Disease | 8 | 2020 | 9384 | 0.110 |
Why?
|
| Liver Cirrhosis | 3 | 2010 | 1960 | 0.110 |
Why?
|
| Antiprotozoal Agents | 1 | 2014 | 95 | 0.110 |
Why?
|
| Glutathione Transferase | 2 | 2007 | 564 | 0.110 |
Why?
|
| Metabolome | 1 | 2020 | 1009 | 0.110 |
Why?
|
| Stress, Physiological | 2 | 2013 | 1408 | 0.110 |
Why?
|
| Prostate-Specific Antigen | 2 | 2000 | 2463 | 0.110 |
Why?
|
| Nucleoproteins | 1 | 2013 | 110 | 0.110 |
Why?
|
| Trypsin Inhibitors | 1 | 2012 | 32 | 0.110 |
Why?
|
| Herpesvirus 4, Human | 2 | 2014 | 1082 | 0.110 |
Why?
|
| Repressor Proteins | 3 | 2000 | 2982 | 0.110 |
Why?
|
| Heart-Assist Devices | 1 | 2024 | 1292 | 0.110 |
Why?
|
| Insulin-Secreting Cells | 3 | 2012 | 899 | 0.100 |
Why?
|
| Prognosis | 11 | 2021 | 30010 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2015 | 414 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2011 | 11878 | 0.100 |
Why?
|
| Th2 Cells | 1 | 2018 | 1078 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2020 | 1275 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2008 | 4530 | 0.100 |
Why?
|
| Triticum | 1 | 2012 | 92 | 0.100 |
Why?
|
| Neoplasm Metastasis | 5 | 2020 | 4912 | 0.100 |
Why?
|
| Bone Marrow | 3 | 2019 | 2935 | 0.100 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2024 | 1483 | 0.100 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2012 | 109 | 0.100 |
Why?
|
| Antigens, CD | 3 | 2008 | 4035 | 0.100 |
Why?
|
| Dysmenorrhea | 2 | 2024 | 107 | 0.100 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2010 | 778 | 0.100 |
Why?
|
| Cardioplegic Solutions | 1 | 2012 | 123 | 0.100 |
Why?
|
| Plasmids | 4 | 2005 | 2269 | 0.100 |
Why?
|
| Transduction, Genetic | 5 | 2010 | 899 | 0.100 |
Why?
|
| Logistic Models | 3 | 2024 | 13290 | 0.100 |
Why?
|
| Alzheimer Disease | 2 | 2024 | 8759 | 0.100 |
Why?
|
| Mice, Inbred DBA | 4 | 2006 | 624 | 0.100 |
Why?
|
| Mind-Body Therapies | 1 | 2015 | 294 | 0.100 |
Why?
|
| Parathyroid Hormone | 2 | 2011 | 1804 | 0.100 |
Why?
|
| Neoplasms | 7 | 2012 | 22371 | 0.100 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2021 | 1334 | 0.100 |
Why?
|
| Sequence Alignment | 4 | 2001 | 2179 | 0.090 |
Why?
|
| Prostate | 1 | 2000 | 1765 | 0.090 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2010 | 102 | 0.090 |
Why?
|
| Disease Progression | 6 | 2021 | 13671 | 0.090 |
Why?
|
| Diclofenac | 1 | 2011 | 69 | 0.090 |
Why?
|
| Drug Synergism | 3 | 2011 | 1760 | 0.090 |
Why?
|
| Hepatitis C, Chronic | 2 | 2010 | 1032 | 0.090 |
Why?
|
| Prostatic Hyperplasia | 1 | 2015 | 516 | 0.090 |
Why?
|
| Mucin-6 | 1 | 2010 | 15 | 0.090 |
Why?
|
| Glioma | 4 | 1994 | 3503 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2011 | 693 | 0.090 |
Why?
|
| Serine-Type D-Ala-D-Ala Carboxypeptidase | 1 | 2010 | 16 | 0.090 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2013 | 149 | 0.090 |
Why?
|
| Cell Proliferation | 9 | 2023 | 10474 | 0.090 |
Why?
|
| Follow-Up Studies | 7 | 2024 | 39348 | 0.090 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2007 | 1097 | 0.090 |
Why?
|
| Synaptosomes | 2 | 2008 | 116 | 0.090 |
Why?
|
| Immune System | 2 | 2013 | 799 | 0.090 |
Why?
|
| Pregnancy | 8 | 2023 | 30256 | 0.090 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2010 | 56 | 0.090 |
Why?
|
| Cell Adhesion | 5 | 2014 | 3096 | 0.090 |
Why?
|
| Sesquiterpenes | 1 | 2011 | 175 | 0.090 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 1990 | 62 | 0.090 |
Why?
|
| Boronic Acids | 3 | 2005 | 915 | 0.090 |
Why?
|
| Carcinoma in Situ | 1 | 2016 | 788 | 0.090 |
Why?
|
| Benzenesulfonates | 1 | 2011 | 170 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2010 | 3610 | 0.090 |
Why?
|
| Breast Neoplasms | 3 | 2020 | 21206 | 0.090 |
Why?
|
| Plant Proteins | 1 | 2012 | 376 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2020 | 2167 | 0.090 |
Why?
|
| Collagen Type X | 1 | 2010 | 16 | 0.090 |
Why?
|
| Cyclic AMP | 1 | 1994 | 1470 | 0.090 |
Why?
|
| Epithelial Cells | 4 | 2007 | 3703 | 0.090 |
Why?
|
| United States | 7 | 2024 | 73039 | 0.090 |
Why?
|
| HeLa Cells | 6 | 2004 | 3074 | 0.090 |
Why?
|
| Oncogene Proteins | 1 | 1994 | 717 | 0.090 |
Why?
|
| Cell Death | 1 | 2015 | 1679 | 0.080 |
Why?
|
| Rabbits | 3 | 2012 | 4772 | 0.080 |
Why?
|
| Epithelium | 3 | 2000 | 1607 | 0.080 |
Why?
|
| Hepatic Stellate Cells | 1 | 2010 | 117 | 0.080 |
Why?
|
| Alpha-Amanitin | 1 | 2009 | 7 | 0.080 |
Why?
|
| DNA Damage | 5 | 2006 | 2469 | 0.080 |
Why?
|
| Young Adult | 13 | 2024 | 60066 | 0.080 |
Why?
|
| Length of Stay | 2 | 2021 | 6498 | 0.080 |
Why?
|
| Adenoviruses, Human | 2 | 2002 | 257 | 0.080 |
Why?
|
| Hydroxamic Acids | 1 | 2012 | 483 | 0.080 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2015 | 454 | 0.080 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2004 | 355 | 0.080 |
Why?
|
| Blotting, Northern | 4 | 2004 | 1550 | 0.080 |
Why?
|
| Genes, Immunoglobulin | 1 | 1990 | 286 | 0.080 |
Why?
|
| Proteins | 2 | 2020 | 6009 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2012 | 2810 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2008 | 9 | 0.080 |
Why?
|
| Cornified Envelope Proline-Rich Proteins | 2 | 1999 | 15 | 0.080 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 588 | 0.080 |
Why?
|
| Cycloheximide | 1 | 2009 | 341 | 0.080 |
Why?
|
| I-kappa B Proteins | 3 | 2005 | 210 | 0.080 |
Why?
|
| Rats, Wistar | 5 | 2008 | 1888 | 0.080 |
Why?
|
| Cell-Derived Microparticles | 1 | 2010 | 160 | 0.080 |
Why?
|
| Brain Neoplasms | 5 | 2006 | 9118 | 0.080 |
Why?
|
| Luciferases | 5 | 2005 | 713 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1999 | 2909 | 0.080 |
Why?
|
| Mass Spectrometry | 3 | 2021 | 2202 | 0.080 |
Why?
|
| Purkinje Cells | 1 | 2010 | 228 | 0.080 |
Why?
|
| Fibroblasts | 9 | 2014 | 4176 | 0.080 |
Why?
|
| Pyrazines | 3 | 2005 | 1205 | 0.080 |
Why?
|
| Cell Transformation, Viral | 2 | 2007 | 530 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2023 | 2973 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2021 | 2496 | 0.080 |
Why?
|
| Nitric Oxide | 2 | 2018 | 2146 | 0.080 |
Why?
|
| Immunity, Innate | 2 | 2018 | 3080 | 0.080 |
Why?
|
| Risk Assessment | 4 | 2025 | 24315 | 0.080 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2013 | 365 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2004 | 3781 | 0.080 |
Why?
|
| Cell Movement | 3 | 2016 | 5210 | 0.080 |
Why?
|
| Homeostasis | 2 | 2010 | 3348 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 4 | 2015 | 4413 | 0.070 |
Why?
|
| Risk Factors | 8 | 2025 | 74944 | 0.070 |
Why?
|
| Nerve Endings | 1 | 2008 | 103 | 0.070 |
Why?
|
| Osteoarthritis | 2 | 2008 | 1072 | 0.070 |
Why?
|
| Fetal Blood | 2 | 2012 | 1361 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2024 | 5812 | 0.070 |
Why?
|
| Transcription Factor RelA | 3 | 2005 | 252 | 0.070 |
Why?
|
| Metabolism | 1 | 2009 | 193 | 0.070 |
Why?
|
| Dendrites | 1 | 2010 | 472 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2020 | 2257 | 0.070 |
Why?
|
| Immunohistochemistry | 9 | 2019 | 11095 | 0.070 |
Why?
|
| Carcinoma 256, Walker | 1 | 2007 | 37 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 5 | 2007 | 6082 | 0.070 |
Why?
|
| Collagen Type II | 1 | 2008 | 151 | 0.070 |
Why?
|
| Culture Media | 2 | 2006 | 898 | 0.070 |
Why?
|
| Incidence | 3 | 2021 | 21538 | 0.070 |
Why?
|
| Microdissection | 1 | 2007 | 150 | 0.070 |
Why?
|
| Mice, Knockout | 6 | 2018 | 14488 | 0.070 |
Why?
|
| Shock, Hemorrhagic | 1 | 2009 | 224 | 0.070 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2012 | 856 | 0.070 |
Why?
|
| Keratins | 2 | 2000 | 499 | 0.070 |
Why?
|
| Longitudinal Studies | 3 | 2024 | 14783 | 0.070 |
Why?
|
| Hyperplasia | 1 | 2010 | 1151 | 0.070 |
Why?
|
| Mucins | 1 | 2010 | 570 | 0.070 |
Why?
|
| Ketosis | 1 | 2007 | 46 | 0.070 |
Why?
|
| Umbilical Veins | 2 | 2005 | 424 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2009 | 1319 | 0.070 |
Why?
|
| Somatomedins | 1 | 2007 | 179 | 0.070 |
Why?
|
| Ketone Bodies | 1 | 2007 | 76 | 0.070 |
Why?
|
| Pyrophosphatases | 1 | 2007 | 142 | 0.070 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2013 | 707 | 0.070 |
Why?
|
| Rats | 13 | 2009 | 23760 | 0.070 |
Why?
|
| Adenosine Triphosphate | 4 | 2008 | 2004 | 0.070 |
Why?
|
| Aging | 5 | 2023 | 8744 | 0.070 |
Why?
|
| Genes, Reporter | 5 | 2005 | 1524 | 0.070 |
Why?
|
| Restriction Mapping | 3 | 1993 | 849 | 0.070 |
Why?
|
| Mice, Inbred NOD | 4 | 2015 | 1837 | 0.070 |
Why?
|
| Epigenomics | 1 | 2012 | 960 | 0.070 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2007 | 205 | 0.070 |
Why?
|
| Metalloendopeptidases | 2 | 2005 | 386 | 0.070 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2007 | 195 | 0.070 |
Why?
|
| DNA | 11 | 2005 | 7214 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 4 | 2014 | 3772 | 0.070 |
Why?
|
| Time Factors | 11 | 2024 | 40218 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 1560 | 0.070 |
Why?
|
| GTP-Binding Proteins | 1 | 2010 | 948 | 0.070 |
Why?
|
| Multiple Myeloma | 6 | 2005 | 5196 | 0.070 |
Why?
|
| Precipitin Tests | 2 | 2004 | 816 | 0.060 |
Why?
|
| Islets of Langerhans | 1 | 2012 | 1351 | 0.060 |
Why?
|
| Interferon-alpha | 1 | 2010 | 910 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2020 | 1942 | 0.060 |
Why?
|
| Shock, Septic | 1 | 2012 | 774 | 0.060 |
Why?
|
| Gene Amplification | 3 | 1985 | 1095 | 0.060 |
Why?
|
| MicroRNAs | 2 | 2020 | 3803 | 0.060 |
Why?
|
| Pregnancy, Animal | 1 | 2006 | 124 | 0.060 |
Why?
|
| Anthracenes | 1 | 2005 | 83 | 0.060 |
Why?
|
| Rifabutin | 1 | 2005 | 59 | 0.060 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2007 | 342 | 0.060 |
Why?
|
| Esophageal Neoplasms | 2 | 2015 | 1668 | 0.060 |
Why?
|
| Adolescent | 13 | 2024 | 89169 | 0.060 |
Why?
|
| NF-kappa B p50 Subunit | 2 | 2003 | 103 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1999 | 1057 | 0.060 |
Why?
|
| Disintegrins | 1 | 2005 | 27 | 0.060 |
Why?
|
| Muscle Proteins | 2 | 2010 | 1165 | 0.060 |
Why?
|
| Endothelium | 2 | 2004 | 768 | 0.060 |
Why?
|
| Tumor Burden | 1 | 2011 | 1906 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 11 | 2012 | 22379 | 0.060 |
Why?
|
| Human papillomavirus 16 | 1 | 2007 | 268 | 0.060 |
Why?
|
| Epidermal Growth Factor | 8 | 1998 | 697 | 0.060 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 1469 | 0.060 |
Why?
|
| Nucleotides | 1 | 2008 | 455 | 0.060 |
Why?
|
| 3T3 Cells | 3 | 2002 | 1084 | 0.060 |
Why?
|
| Adult Stem Cells | 1 | 2007 | 221 | 0.060 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2005 | 384 | 0.060 |
Why?
|
| Chromatography, Liquid | 1 | 2009 | 996 | 0.060 |
Why?
|
| Quinazolinones | 1 | 2006 | 219 | 0.060 |
Why?
|
| Autocrine Communication | 1 | 2006 | 168 | 0.060 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2008 | 373 | 0.060 |
Why?
|
| Collagenases | 1 | 2005 | 221 | 0.060 |
Why?
|
| Growth Substances | 1 | 1987 | 759 | 0.060 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2008 | 410 | 0.060 |
Why?
|
| Integrins | 2 | 2007 | 842 | 0.060 |
Why?
|
| DNA Modification Methylases | 1 | 2005 | 208 | 0.060 |
Why?
|
| Phosphoproteins | 2 | 2013 | 2451 | 0.060 |
Why?
|
| Celiac Disease | 1 | 2012 | 820 | 0.060 |
Why?
|
| Apyrase | 1 | 2007 | 376 | 0.060 |
Why?
|
| Urine | 1 | 2006 | 362 | 0.060 |
Why?
|
| Lasers | 2 | 2007 | 952 | 0.060 |
Why?
|
| Protein Precursors | 2 | 1999 | 1134 | 0.060 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2005 | 189 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 4 | 2010 | 1369 | 0.060 |
Why?
|
| Muscle Contraction | 1 | 2009 | 1209 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2021 | 12252 | 0.060 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2007 | 263 | 0.060 |
Why?
|
| Multivariate Analysis | 5 | 2025 | 12077 | 0.060 |
Why?
|
| Jurkat Cells | 3 | 2015 | 740 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 7 | 2015 | 4058 | 0.060 |
Why?
|
| Mesoderm | 1 | 2007 | 679 | 0.060 |
Why?
|
| Thrombosis | 1 | 2018 | 2957 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2011 | 5341 | 0.060 |
Why?
|
| Sepsis | 1 | 2018 | 2608 | 0.060 |
Why?
|
| Azacitidine | 1 | 2005 | 336 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 2 | 2005 | 1703 | 0.060 |
Why?
|
| Transplantation, Homologous | 2 | 2006 | 4833 | 0.060 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2012 | 1124 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2018 | 18065 | 0.060 |
Why?
|
| Leukemia, B-Cell | 1 | 2004 | 86 | 0.060 |
Why?
|
| Retinoblastoma Protein | 1 | 2007 | 671 | 0.050 |
Why?
|
| Catenins | 1 | 2023 | 44 | 0.050 |
Why?
|
| Angiopoietin-1 | 1 | 2004 | 133 | 0.050 |
Why?
|
| Cadherins | 1 | 2008 | 905 | 0.050 |
Why?
|
| Leukemia, Myeloid | 1 | 2006 | 693 | 0.050 |
Why?
|
| Alternative Splicing | 2 | 1999 | 1105 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 4786 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 1143 | 0.050 |
Why?
|
| Albumins | 1 | 2006 | 577 | 0.050 |
Why?
|
| Glioblastoma | 3 | 2006 | 3464 | 0.050 |
Why?
|
| Recombinant Proteins | 4 | 2014 | 6514 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2016 | 2295 | 0.050 |
Why?
|
| High Mobility Group Proteins | 2 | 2008 | 179 | 0.050 |
Why?
|
| Research Design | 2 | 2017 | 6211 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2009 | 2885 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 1338 | 0.050 |
Why?
|
| Cricetinae | 2 | 1999 | 2423 | 0.050 |
Why?
|
| NFATC Transcription Factors | 1 | 2005 | 393 | 0.050 |
Why?
|
| Xeroderma Pigmentosum | 1 | 2002 | 31 | 0.050 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2002 | 122 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2012 | 3447 | 0.050 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2005 | 423 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2010 | 1494 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2009 | 1197 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 598 | 0.050 |
Why?
|
| Genetic Markers | 3 | 2018 | 2603 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2007 | 1245 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2011 | 1904 | 0.050 |
Why?
|
| Herpesvirus 8, Human | 1 | 2004 | 256 | 0.050 |
Why?
|
| Pilot Projects | 3 | 2022 | 8741 | 0.050 |
Why?
|
| Granulocytes | 2 | 2019 | 551 | 0.050 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2002 | 185 | 0.050 |
Why?
|
| Heart Ventricles | 3 | 2012 | 3841 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 5 | 1987 | 1305 | 0.050 |
Why?
|
| COS Cells | 1 | 2004 | 1135 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 2 | 2005 | 911 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 2429 | 0.050 |
Why?
|
| Cognition | 2 | 2020 | 7073 | 0.050 |
Why?
|
| Models, Biological | 8 | 2008 | 9495 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2010 | 2359 | 0.050 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2005 | 646 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2007 | 3620 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 26379 | 0.050 |
Why?
|
| Serine | 1 | 2005 | 831 | 0.050 |
Why?
|
| Chemokines, CC | 1 | 2002 | 286 | 0.050 |
Why?
|
| Protein Transport | 2 | 2005 | 1951 | 0.050 |
Why?
|
| Peptides | 3 | 2010 | 4354 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 3 | 2010 | 321 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 3239 | 0.050 |
Why?
|
| Chromosome Mapping | 4 | 1997 | 4620 | 0.050 |
Why?
|
| Exons | 3 | 2010 | 2394 | 0.050 |
Why?
|
| Kidney | 6 | 2021 | 7064 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 4 | 1999 | 826 | 0.050 |
Why?
|
| Lymphatic System | 1 | 2003 | 251 | 0.050 |
Why?
|
| Chemokine CCL5 | 1 | 2002 | 214 | 0.050 |
Why?
|
| Treatment Outcome | 7 | 2024 | 65371 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 1987 | 873 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 1250 | 0.050 |
Why?
|
| Cartilage, Articular | 1 | 2008 | 1104 | 0.050 |
Why?
|
| CpG Islands | 1 | 2005 | 1208 | 0.040 |
Why?
|
| Swine Diseases | 1 | 2020 | 61 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2018 | 514 | 0.040 |
Why?
|
| Bone Resorption | 1 | 2004 | 728 | 0.040 |
Why?
|
| Membrane Glycoproteins | 3 | 2001 | 3711 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2008 | 1997 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2000 | 58 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2013 | 3591 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2015 | 2442 | 0.040 |
Why?
|
| Androgens | 2 | 2005 | 1281 | 0.040 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2020 | 71 | 0.040 |
Why?
|
| Selection Bias | 1 | 2022 | 360 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 2020 | 24 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2020 | 28 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2003 | 910 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2006 | 3626 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2000 | 229 | 0.040 |
Why?
|
| Lymphatic Vessels | 1 | 2004 | 356 | 0.040 |
Why?
|
| Cell Line, Transformed | 2 | 2002 | 866 | 0.040 |
Why?
|
| Salivary Proteins and Peptides | 1 | 1999 | 48 | 0.040 |
Why?
|
| Mitochondria | 1 | 2013 | 3681 | 0.040 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2020 | 60 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 2004 | 2094 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2015 | 2014 | 0.040 |
Why?
|
| Gene Products, gag | 1 | 2000 | 318 | 0.040 |
Why?
|
| Receptors, Chemokine | 1 | 2002 | 652 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 36743 | 0.040 |
Why?
|
| Bradykinin | 1 | 1999 | 205 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2002 | 439 | 0.040 |
Why?
|
| Endocrine System | 1 | 2020 | 113 | 0.040 |
Why?
|
| Oncogenes | 4 | 2003 | 1234 | 0.040 |
Why?
|
| Lipomatosis | 1 | 2020 | 112 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 664 | 0.040 |
Why?
|
| In Situ Hybridization | 4 | 2005 | 1903 | 0.040 |
Why?
|
| Pyridines | 1 | 2011 | 2894 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2009 | 1923 | 0.040 |
Why?
|
| Kinetics | 6 | 2008 | 6329 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2004 | 1715 | 0.040 |
Why?
|
| Protease Inhibitors | 1 | 2002 | 751 | 0.040 |
Why?
|
| Goldfish | 1 | 1998 | 64 | 0.040 |
Why?
|
| HEK293 Cells | 3 | 2013 | 4283 | 0.040 |
Why?
|
| Dietary Fats | 1 | 2007 | 2003 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2010 | 1134 | 0.040 |
Why?
|
| Animals, Newborn | 3 | 2012 | 2678 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2003 | 874 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 2020 | 521 | 0.040 |
Why?
|
| Sarcoma | 1 | 2010 | 1806 | 0.040 |
Why?
|
| Temperature | 1 | 2005 | 2234 | 0.040 |
Why?
|
| Plasma | 1 | 2022 | 585 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2022 | 677 | 0.040 |
Why?
|
| Mice, Inbred C3H | 2 | 2012 | 915 | 0.040 |
Why?
|
| Consensus Sequence | 2 | 1996 | 363 | 0.040 |
Why?
|
| Parotid Gland | 1 | 1999 | 178 | 0.040 |
Why?
|
| Genome | 1 | 2007 | 1754 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2020 | 563 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2004 | 1683 | 0.040 |
Why?
|
| Child | 8 | 2022 | 80917 | 0.040 |
Why?
|
| Sodium Azide | 2 | 2008 | 24 | 0.040 |
Why?
|
| beta Catenin | 1 | 2023 | 1047 | 0.040 |
Why?
|
| Suramin | 2 | 2008 | 34 | 0.040 |
Why?
|
| Bone Marrow Diseases | 1 | 2020 | 234 | 0.040 |
Why?
|
| Piperidines | 1 | 2006 | 1667 | 0.040 |
Why?
|
| Psychomotor Performance | 2 | 2020 | 1892 | 0.040 |
Why?
|
| Cell Communication | 1 | 2005 | 1660 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 3 | 2005 | 617 | 0.040 |
Why?
|
| Child, Preschool | 6 | 2021 | 42669 | 0.040 |
Why?
|
| Matrix Metalloproteinase 13 | 2 | 2010 | 101 | 0.040 |
Why?
|
| Genes, Regulator | 1 | 1998 | 373 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 1676 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2004 | 1320 | 0.040 |
Why?
|
| Adenoviridae Infections | 1 | 1998 | 96 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2020 | 587 | 0.040 |
Why?
|
| Bone and Bones | 2 | 2005 | 2589 | 0.040 |
Why?
|
| Estradiol | 1 | 2004 | 1951 | 0.040 |
Why?
|
| Transplantation, Isogeneic | 1 | 1997 | 249 | 0.030 |
Why?
|
| Lymphocyte Depletion | 1 | 1999 | 605 | 0.030 |
Why?
|
| Myosin Heavy Chains | 1 | 1998 | 404 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20760 | 0.030 |
Why?
|
| Endocytosis | 2 | 2020 | 956 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2023 | 1070 | 0.030 |
Why?
|
| Angiopoietin-2 | 1 | 2018 | 186 | 0.030 |
Why?
|
| Phenotype | 5 | 2020 | 16726 | 0.030 |
Why?
|
| Hydrolysis | 2 | 2008 | 646 | 0.030 |
Why?
|
| Poly A | 2 | 1994 | 180 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2004 | 2675 | 0.030 |
Why?
|
| Fetal Proteins | 1 | 1996 | 100 | 0.030 |
Why?
|
| CHO Cells | 1 | 1999 | 1379 | 0.030 |
Why?
|
| Introns | 1 | 1999 | 966 | 0.030 |
Why?
|
| Muscle, Skeletal | 2 | 2003 | 4978 | 0.030 |
Why?
|
| Mice, Transgenic | 4 | 2010 | 9561 | 0.030 |
Why?
|
| Immunoglobulin E | 2 | 2018 | 1506 | 0.030 |
Why?
|
| Parenteral Nutrition | 1 | 2020 | 663 | 0.030 |
Why?
|
| Adenosine Diphosphate | 2 | 2008 | 422 | 0.030 |
Why?
|
| Fibronectins | 2 | 2018 | 722 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 1997 | 556 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2000 | 1083 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1994 | 705 | 0.030 |
Why?
|
| Leukemia | 1 | 2004 | 1519 | 0.030 |
Why?
|
| Teriparatide | 1 | 1997 | 226 | 0.030 |
Why?
|
| Dinoprostone | 2 | 1997 | 597 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 2004 | 2191 | 0.030 |
Why?
|
| Hematopoiesis | 2 | 2019 | 2059 | 0.030 |
Why?
|
| Apolipoprotein E4 | 1 | 2020 | 712 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 2018 | 564 | 0.030 |
Why?
|
| Prednisone | 1 | 2020 | 1567 | 0.030 |
Why?
|
| Retina | 2 | 2003 | 2662 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2005 | 2954 | 0.030 |
Why?
|
| Fibrinogen | 1 | 2018 | 891 | 0.030 |
Why?
|
| Bucladesine | 1 | 1994 | 118 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2021 | 791 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 1997 | 1765 | 0.030 |
Why?
|
| Alprostadil | 1 | 1994 | 86 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2018 | 680 | 0.030 |
Why?
|
| Stem Cells | 2 | 2006 | 3537 | 0.030 |
Why?
|
| Cell Lineage | 2 | 2019 | 2575 | 0.030 |
Why?
|
| Theophylline | 1 | 1994 | 133 | 0.030 |
Why?
|
| Hybrid Cells | 1 | 1994 | 421 | 0.030 |
Why?
|
| Cell Count | 1 | 2018 | 1832 | 0.030 |
Why?
|
| Pseudomonas Infections | 1 | 2018 | 623 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 580 | 0.030 |
Why?
|
| RNA, Neoplasm | 2 | 2008 | 749 | 0.030 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1993 | 74 | 0.030 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2013 | 40 | 0.030 |
Why?
|
| Connective Tissue | 1 | 1996 | 425 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2005 | 11244 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2009 | 4755 | 0.030 |
Why?
|
| Viral Structural Proteins | 1 | 2013 | 93 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2018 | 1194 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2007 | 3980 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2024 | 1765 | 0.030 |
Why?
|
| Misoprostol | 1 | 1994 | 94 | 0.030 |
Why?
|
| Extracellular Space | 2 | 2008 | 563 | 0.030 |
Why?
|
| Hordeum | 1 | 2012 | 18 | 0.030 |
Why?
|
| DNA Repair | 1 | 2002 | 2050 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2005 | 2541 | 0.030 |
Why?
|
| DNA Probes | 1 | 1994 | 542 | 0.030 |
Why?
|
| Acute Disease | 2 | 2018 | 7243 | 0.030 |
Why?
|
| Cartilage | 2 | 2008 | 811 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 422 | 0.030 |
Why?
|
| Gliadin | 1 | 2012 | 80 | 0.030 |
Why?
|
| Endothelial Growth Factors | 2 | 2003 | 671 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1998 | 1207 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1994 | 1142 | 0.030 |
Why?
|
| Enzyme Inhibitors | 4 | 2007 | 3728 | 0.030 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2013 | 129 | 0.030 |
Why?
|
| Isoenzymes | 2 | 2008 | 1688 | 0.030 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2022 | 1490 | 0.030 |
Why?
|
| U937 Cells | 1 | 2012 | 260 | 0.030 |
Why?
|
| Bone Marrow Cells | 3 | 2009 | 2414 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 2227 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2012 | 61 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 1738 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 2006 | 1751 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 2018 | 1162 | 0.020 |
Why?
|
| Ovariectomy | 2 | 2004 | 613 | 0.020 |
Why?
|
| Receptors, TIE | 2 | 2002 | 10 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2024 | 2041 | 0.020 |
Why?
|
| Receptor, TIE-1 | 2 | 2002 | 13 | 0.020 |
Why?
|
| Phylogeny | 1 | 2000 | 2843 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 1994 | 438 | 0.020 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2012 | 126 | 0.020 |
Why?
|
| Intestines | 1 | 2021 | 1909 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1994 | 781 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2014 | 488 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2004 | 1907 | 0.020 |
Why?
|
| Ligation | 1 | 2012 | 446 | 0.020 |
Why?
|
| Fasting | 1 | 2018 | 1610 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2012 | 210 | 0.020 |
Why?
|
| Hepatocytes | 2 | 2011 | 1247 | 0.020 |
Why?
|
| RNA Splicing | 1 | 1996 | 905 | 0.020 |
Why?
|
| Viral Proteins | 2 | 1992 | 1802 | 0.020 |
Why?
|
| Disease Models, Animal | 4 | 2012 | 18349 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 10760 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 5889 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 369 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2000 | 3160 | 0.020 |
Why?
|
| T-Lymphocytes | 3 | 2012 | 10266 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2012 | 417 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1998 | 1493 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 2748 | 0.020 |
Why?
|
| Bone Density | 1 | 2004 | 3573 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1997 | 2521 | 0.020 |
Why?
|
| Immune Tolerance | 2 | 2012 | 2323 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 7 | 2012 | 9263 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2040 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2005 | 4428 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 2012 | 236 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 1994 | 1162 | 0.020 |
Why?
|
| Swine | 1 | 2020 | 5995 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 948 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2002 | 3740 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1990 | 221 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2010 | 128 | 0.020 |
Why?
|
| Tubulin | 1 | 1994 | 695 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 4 | 1 | 2010 | 3 | 0.020 |
Why?
|
| Algorithms | 2 | 2008 | 14164 | 0.020 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2010 | 20 | 0.020 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 2010 | 20 | 0.020 |
Why?
|
| Teratocarcinoma | 1 | 2010 | 16 | 0.020 |
Why?
|
| Epitopes | 4 | 2002 | 2528 | 0.020 |
Why?
|
| Activating Transcription Factor 1 | 1 | 2010 | 26 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2012 | 501 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 1805 | 0.020 |
Why?
|
| Expert Systems | 1 | 2010 | 79 | 0.020 |
Why?
|
| DNA, Viral | 2 | 1998 | 2204 | 0.020 |
Why?
|
| Ubiquitin | 2 | 2007 | 843 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1992 | 435 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2010 | 56 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2021 | 5315 | 0.020 |
Why?
|
| Lung | 2 | 2022 | 10099 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2004 | 5919 | 0.020 |
Why?
|
| tau Proteins | 1 | 2020 | 2144 | 0.020 |
Why?
|
| RNA | 3 | 2008 | 2720 | 0.020 |
Why?
|
| Acetylation | 1 | 2012 | 1056 | 0.020 |
Why?
|
| Chick Embryo | 2 | 2002 | 975 | 0.020 |
Why?
|
| Chickens | 2 | 2002 | 845 | 0.020 |
Why?
|
| Astrocytoma | 1 | 1994 | 774 | 0.020 |
Why?
|
| Boston | 1 | 2022 | 9374 | 0.020 |
Why?
|
| Rats, Inbred WKY | 1 | 2009 | 150 | 0.020 |
Why?
|
| Virus Replication | 1 | 1997 | 2458 | 0.020 |
Why?
|
| Databases, Nucleic Acid | 1 | 2010 | 204 | 0.020 |
Why?
|
| Feces | 1 | 2016 | 1511 | 0.020 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2011 | 2056 | 0.020 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2012 | 483 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2015 | 1505 | 0.020 |
Why?
|
| Genotype | 2 | 2020 | 13045 | 0.020 |
Why?
|
| Lymph Nodes | 2 | 2012 | 3474 | 0.020 |
Why?
|
| Niacinamide | 1 | 2011 | 418 | 0.020 |
Why?
|
| Models, Genetic | 1 | 1999 | 3447 | 0.020 |
Why?
|
| DNA Mutational Analysis | 2 | 2004 | 4120 | 0.020 |
Why?
|
| SOXC Transcription Factors | 1 | 2008 | 41 | 0.020 |
Why?
|
| Simplexvirus | 1 | 1992 | 805 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2014 | 1327 | 0.020 |
Why?
|
| Alleles | 1 | 2020 | 6894 | 0.020 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2008 | 51 | 0.020 |
Why?
|
| Systems Biology | 1 | 2012 | 482 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 582 | 0.020 |
Why?
|
| Glycolysis | 1 | 2012 | 837 | 0.020 |
Why?
|
| Premature Birth | 1 | 2020 | 1829 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2010 | 794 | 0.020 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2008 | 66 | 0.020 |
Why?
|
| Cystatins | 1 | 2008 | 55 | 0.020 |
Why?
|
| Thymidine Monophosphate | 1 | 2007 | 2 | 0.020 |
Why?
|
| Macrophages | 1 | 2003 | 5799 | 0.020 |
Why?
|
| Growth Plate | 1 | 2010 | 276 | 0.020 |
Why?
|
| Sequence Analysis, Protein | 1 | 2009 | 264 | 0.020 |
Why?
|
| Receptors, Virus | 2 | 2002 | 652 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2012 | 737 | 0.020 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2007 | 46 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 294 | 0.020 |
Why?
|
| Ouabain | 1 | 2008 | 246 | 0.020 |
Why?
|
| Anxiety | 1 | 2023 | 4672 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 492 | 0.020 |
Why?
|
| Biological Evolution | 1 | 1993 | 1076 | 0.020 |
Why?
|
| Tissue Banks | 1 | 2008 | 183 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 3114 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 2149 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 7140 | 0.020 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2007 | 110 | 0.020 |
Why?
|
| Thioacetamide | 1 | 2006 | 22 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 500 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2002 | 6611 | 0.020 |
Why?
|
| alpha-Fetoproteins | 1 | 2008 | 229 | 0.020 |
Why?
|
| Paraffin Embedding | 1 | 2008 | 307 | 0.020 |
Why?
|
| ROC Curve | 1 | 2015 | 3628 | 0.020 |
Why?
|
| Nitrophenols | 1 | 2007 | 169 | 0.020 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2007 | 72 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 2006 | 141 | 0.020 |
Why?
|
| Blood Specimen Collection | 1 | 2008 | 238 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2022 | 6314 | 0.020 |
Why?
|
| Placenta | 2 | 2006 | 1725 | 0.020 |
Why?
|
| Adenylate Kinase | 1 | 2007 | 101 | 0.020 |
Why?
|
| Biopsy | 1 | 2018 | 6793 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2006 | 144 | 0.020 |
Why?
|
| Infant | 2 | 2021 | 36535 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2004 | 1656 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2006 | 166 | 0.020 |
Why?
|
| Cystatin C | 1 | 2008 | 272 | 0.020 |
Why?
|
| Massachusetts | 1 | 2019 | 8890 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2007 | 148 | 0.020 |
Why?
|
| Adenosine Monophosphate | 1 | 2008 | 232 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2012 | 1110 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 2227 | 0.020 |
Why?
|
| Oncogenic Viruses | 1 | 1986 | 37 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1987 | 525 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 2010 | 749 | 0.020 |
Why?
|
| Fos-Related Antigen-2 | 1 | 2005 | 14 | 0.020 |
Why?
|
| Sensitivity and Specificity | 3 | 2008 | 14729 | 0.020 |
Why?
|
| Globins | 1 | 2006 | 405 | 0.020 |
Why?
|
| Transplantation, Heterologous | 2 | 2004 | 2393 | 0.020 |
Why?
|
| Integrin alpha2beta1 | 1 | 2005 | 17 | 0.020 |
Why?
|
| Protein Kinase C | 2 | 2001 | 1207 | 0.020 |
Why?
|
| Integrin alpha6beta4 | 1 | 2005 | 30 | 0.020 |
Why?
|
| Smad1 Protein | 1 | 2005 | 81 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2005 | 2457 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2008 | 547 | 0.020 |
Why?
|
| Quality Control | 1 | 2008 | 836 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 15948 | 0.020 |
Why?
|
| raf Kinases | 1 | 2005 | 117 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 1 | 1 | 2004 | 11 | 0.020 |
Why?
|
| Meningioma | 1 | 1994 | 1220 | 0.020 |
Why?
|
| Benzoquinones | 1 | 2005 | 198 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2005 | 351 | 0.020 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2004 | 43 | 0.010 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2005 | 157 | 0.010 |
Why?
|
| Osteopontin | 1 | 2006 | 306 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2005 | 266 | 0.010 |
Why?
|
| Cathepsin K | 1 | 2004 | 65 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1985 | 1730 | 0.010 |
Why?
|
| Meningeal Neoplasms | 1 | 1994 | 1253 | 0.010 |
Why?
|
| Diet | 1 | 2023 | 8089 | 0.010 |
Why?
|
| Disease | 1 | 2010 | 675 | 0.010 |
Why?
|
| Comorbidity | 1 | 2019 | 10590 | 0.010 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2004 | 44 | 0.010 |
Why?
|
| Molecular Weight | 2 | 1984 | 2173 | 0.010 |
Why?
|
| Caloric Restriction | 1 | 2007 | 301 | 0.010 |
Why?
|
| Genes, cdc | 1 | 2004 | 113 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 1966 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 2005 | 250 | 0.010 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 2298 | 0.010 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2005 | 224 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 9514 | 0.010 |
Why?
|
| Protein Phosphatase 1 | 1 | 2004 | 135 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 432 | 0.010 |
Why?
|
| Genes, jun | 1 | 2003 | 69 | 0.010 |
Why?
|
| Integrin alpha6 | 1 | 2003 | 30 | 0.010 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2005 | 218 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2008 | 2300 | 0.010 |
Why?
|
| CREB-Binding Protein | 1 | 2004 | 147 | 0.010 |
Why?
|
| Lactams, Macrocyclic | 1 | 2005 | 319 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2007 | 1183 | 0.010 |
Why?
|
| Laminin | 1 | 2005 | 405 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 6669 | 0.010 |
Why?
|
| Cathepsins | 1 | 2004 | 243 | 0.010 |
Why?
|
| ADAM Proteins | 1 | 2005 | 242 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2005 | 344 | 0.010 |
Why?
|
| Genes, fos | 1 | 2003 | 176 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1987 | 1534 | 0.010 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2005 | 430 | 0.010 |
Why?
|
| Asthma | 1 | 2002 | 6291 | 0.010 |
Why?
|
| Pandemics | 1 | 2023 | 8748 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2007 | 10101 | 0.010 |
Why?
|
| Ligands | 2 | 2002 | 3284 | 0.010 |
Why?
|
| E-Selectin | 1 | 2005 | 577 | 0.010 |
Why?
|
| Risk | 1 | 2015 | 9613 | 0.010 |
Why?
|
| Sp3 Transcription Factor | 1 | 2002 | 30 | 0.010 |
Why?
|
| Xeroderma Pigmentosum Group A Protein | 1 | 2002 | 13 | 0.010 |
Why?
|
| Cerebellum | 1 | 2010 | 1522 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2006 | 706 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2003 | 530 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2008 | 2486 | 0.010 |
Why?
|
| Survival Rate | 2 | 2009 | 12840 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 693 | 0.010 |
Why?
|
| Immunomagnetic Separation | 1 | 2003 | 78 | 0.010 |
Why?
|
| Depression | 1 | 2023 | 8230 | 0.010 |
Why?
|
| Thrombin | 1 | 2005 | 600 | 0.010 |
Why?
|
| Proto-Oncogenes | 1 | 2003 | 322 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2004 | 327 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1985 | 389 | 0.010 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2005 | 275 | 0.010 |
Why?
|
| Chemokine CCL20 | 1 | 2002 | 64 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2010 | 1862 | 0.010 |
Why?
|
| Glycoproteins | 3 | 2004 | 2202 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 2862 | 0.010 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2002 | 147 | 0.010 |
Why?
|
| Receptors, CCR6 | 1 | 2002 | 73 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 458 | 0.010 |
Why?
|
| Protein Kinases | 3 | 1984 | 1611 | 0.010 |
Why?
|
| Prevalence | 1 | 2019 | 15869 | 0.010 |
Why?
|
| Bone Development | 1 | 2005 | 473 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2003 | 615 | 0.010 |
Why?
|
| NIH 3T3 Cells | 1 | 2004 | 669 | 0.010 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 1027 | 0.010 |
Why?
|
| Sp1 Transcription Factor | 1 | 2002 | 143 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2007 | 2342 | 0.010 |
Why?
|
| Mouth Neoplasms | 1 | 2007 | 597 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2005 | 809 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 2003 | 324 | 0.010 |
Why?
|
| Caco-2 Cells | 1 | 2002 | 366 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 6847 | 0.010 |
Why?
|
| Pregnancy Proteins | 1 | 2003 | 222 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2002 | 557 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2012 | 2138 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6526 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 2004 | 444 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 1982 | 201 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 627 | 0.010 |
Why?
|
| Mitogens | 1 | 1982 | 229 | 0.010 |
Why?
|
| Prolactin | 1 | 1983 | 627 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2006 | 8128 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2006 | 1133 | 0.010 |
Why?
|
| Allantois | 1 | 2001 | 32 | 0.010 |
Why?
|
| Age of Onset | 1 | 2008 | 3347 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2002 | 287 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 3436 | 0.010 |
Why?
|
| Creatinine | 1 | 2007 | 1918 | 0.010 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2005 | 480 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2010 | 1164 | 0.010 |
Why?
|
| ABO Blood-Group System | 1 | 1983 | 381 | 0.010 |
Why?
|
| Melphalan | 1 | 2002 | 421 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2010 | 1596 | 0.010 |
Why?
|
| Chorion | 1 | 2001 | 113 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1983 | 634 | 0.010 |
Why?
|
| Chemotaxis | 1 | 2004 | 600 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2006 | 1737 | 0.010 |
Why?
|
| Synaptotagmin I | 1 | 2000 | 33 | 0.010 |
Why?
|
| Synaptotagmins | 1 | 2000 | 53 | 0.010 |
Why?
|
| Cryopreservation | 1 | 2006 | 733 | 0.010 |
Why?
|
| Motor Activity | 1 | 2010 | 2711 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 2830 | 0.010 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2008 | 1003 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2018 | 13053 | 0.010 |
Why?
|
| India | 1 | 2007 | 2334 | 0.010 |
Why?
|
| Ultraviolet Rays | 2 | 2002 | 1103 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2012 | 3329 | 0.010 |
Why?
|
| Half-Life | 1 | 2001 | 651 | 0.010 |
Why?
|
| Body Fluids | 1 | 1982 | 321 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 542 | 0.010 |
Why?
|
| Lymphokines | 1 | 2003 | 924 | 0.010 |
Why?
|
| Spectrin | 1 | 1980 | 176 | 0.010 |
Why?
|
| Thapsigargin | 1 | 1999 | 102 | 0.010 |
Why?
|
| Response Elements | 1 | 2001 | 307 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 13014 | 0.010 |
Why?
|
| Reference Values | 1 | 2007 | 4938 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2005 | 1336 | 0.010 |
Why?
|
| Tibia | 1 | 2005 | 1076 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 1622 | 0.010 |
Why?
|
| Actins | 2 | 2004 | 2064 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1985 | 1744 | 0.010 |
Why?
|
| Maleimides | 1 | 1999 | 112 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2003 | 1062 | 0.010 |
Why?
|
| ets-Domain Protein Elk-4 | 1 | 1998 | 5 | 0.010 |
Why?
|
| RNA Stability | 1 | 2001 | 319 | 0.010 |
Why?
|
| Postmenopause | 1 | 2008 | 2518 | 0.010 |
Why?
|
| Femur | 1 | 2005 | 1321 | 0.010 |
Why?
|
| DNA Footprinting | 1 | 1998 | 97 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2004 | 998 | 0.010 |
Why?
|
| Chemokine CXCL10 | 1 | 2000 | 311 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2005 | 2089 | 0.010 |
Why?
|
| Cell Membrane | 3 | 1984 | 3655 | 0.010 |
Why?
|
| Erythrocyte Membrane | 1 | 1980 | 438 | 0.010 |
Why?
|
| Estrogens | 1 | 2005 | 1536 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2002 | 931 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2002 | 797 | 0.010 |
Why?
|
| Bronchi | 1 | 2002 | 850 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2003 | 1826 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2003 | 832 | 0.010 |
Why?
|
| Immunoconjugates | 1 | 2006 | 975 | 0.010 |
Why?
|
| Genome, Viral | 1 | 2002 | 674 | 0.010 |
Why?
|
| Benzylamines | 1 | 1999 | 251 | 0.010 |
Why?
|
| Transgenes | 1 | 2002 | 1016 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2004 | 1758 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2009 | 3044 | 0.010 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2002 | 925 | 0.010 |
Why?
|
| Calcimycin | 1 | 1997 | 214 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2010 | 4415 | 0.010 |
Why?
|
| Fever | 1 | 2005 | 1614 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2002 | 1525 | 0.010 |
Why?
|
| Pyrroles | 1 | 2004 | 1124 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2008 | 5505 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2002 | 1997 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1998 | 240 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 1998 | 216 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 2002 | 1831 | 0.010 |
Why?
|
| Gestational Age | 1 | 2006 | 3621 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1998 | 474 | 0.010 |
Why?
|
| Collagen | 1 | 2005 | 2643 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2010 | 4648 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 1997 | 254 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2003 | 1613 | 0.010 |
Why?
|
| Brain | 3 | 2006 | 27360 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2007 | 3139 | 0.010 |
Why?
|
| Connective Tissue Cells | 1 | 1996 | 50 | 0.010 |
Why?
|
| Chromatin | 1 | 2008 | 2981 | 0.010 |
Why?
|
| Transforming Growth Factors | 2 | 1988 | 76 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2004 | 3556 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2002 | 2234 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2002 | 3623 | 0.010 |
Why?
|
| Receptors, Nicotinic | 1 | 1998 | 494 | 0.010 |
Why?
|
| Weight Loss | 1 | 2007 | 2721 | 0.010 |
Why?
|
| Blood Vessels | 1 | 2001 | 1110 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1999 | 1228 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2007 | 2043 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2007 | 26422 | 0.010 |
Why?
|
| Osteoporosis | 1 | 2004 | 1605 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2005 | 2603 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2008 | 3986 | 0.010 |
Why?
|
| Branchioma | 1 | 1953 | 17 | 0.010 |
Why?
|
| Angioplasty, Balloon | 1 | 1998 | 592 | 0.010 |
Why?
|
| Point Mutation | 1 | 1999 | 1596 | 0.010 |
Why?
|
| Zygoma | 1 | 1953 | 52 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5902 | 0.010 |
Why?
|
| ras Proteins | 1 | 1998 | 1058 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1997 | 1419 | 0.010 |
Why?
|
| Cyanogen Bromide | 2 | 1983 | 75 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 12795 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 8542 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 2000 | 1162 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 1996 | 1340 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2004 | 3048 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 1997 | 911 | 0.010 |
Why?
|
| Indoles | 1 | 1999 | 1836 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2001 | 2709 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1980 | 2418 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 81762 | 0.010 |
Why?
|
| Age Factors | 1 | 2007 | 18412 | 0.010 |
Why?
|
| Recurrence | 1 | 2002 | 8509 | 0.010 |
Why?
|
| Obesity | 1 | 2012 | 13090 | 0.010 |
Why?
|
| Sulfonamides | 1 | 1999 | 1982 | 0.010 |
Why?
|
| Internet | 1 | 2002 | 3110 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2006 | 5717 | 0.000 |
Why?
|
| Cysts | 1 | 1953 | 685 | 0.000 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1988 | 178 | 0.000 |
Why?
|
| Chromosomes, Human, 16-18 | 1 | 1985 | 32 | 0.000 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1985 | 69 | 0.000 |
Why?
|
| DNA Replication | 2 | 1983 | 1427 | 0.000 |
Why?
|
| Antibodies | 2 | 1984 | 2421 | 0.000 |
Why?
|
| Oncogene Protein pp60(v-src) | 1 | 1984 | 75 | 0.000 |
Why?
|
| Rodentia | 1 | 1986 | 262 | 0.000 |
Why?
|
| Hemagglutination Tests | 1 | 1983 | 76 | 0.000 |
Why?
|
| Blood Group Antigens | 1 | 1985 | 183 | 0.000 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2002 | 16045 | 0.000 |
Why?
|
| Phosphotyrosine | 1 | 1983 | 458 | 0.000 |
Why?
|
| Antigen-Antibody Complex | 1 | 1984 | 513 | 0.000 |
Why?
|
| Hybridomas | 1 | 1983 | 444 | 0.000 |
Why?
|
| Vinculin | 1 | 1982 | 59 | 0.000 |
Why?
|
| Biophysical Phenomena | 1 | 1983 | 320 | 0.000 |
Why?
|
| Antibody Specificity | 1 | 1983 | 1065 | 0.000 |
Why?
|
| Biophysics | 1 | 1983 | 379 | 0.000 |
Why?
|
| Oligosaccharides | 1 | 1983 | 407 | 0.000 |
Why?
|
| Allosteric Regulation | 1 | 1983 | 426 | 0.000 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1983 | 446 | 0.000 |
Why?
|
| Microinjections | 1 | 1982 | 321 | 0.000 |
Why?
|
| Skin Physiological Phenomena | 1 | 1982 | 193 | 0.000 |
Why?
|
| Affinity Labels | 1 | 1980 | 107 | 0.000 |
Why?
|
| Peptide Fragments | 2 | 1984 | 5151 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1983 | 1435 | 0.000 |
Why?
|
| Caseins | 1 | 1980 | 105 | 0.000 |
Why?
|
| Tyrosine | 1 | 1983 | 1427 | 0.000 |
Why?
|
| Head and Neck Neoplasms | 1 | 1953 | 2931 | 0.000 |
Why?
|
| Surface Properties | 1 | 1982 | 1166 | 0.000 |
Why?
|
| Immunoglobulin M | 1 | 1983 | 1528 | 0.000 |
Why?
|
| Fetus | 1 | 1985 | 1883 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1983 | 3055 | 0.000 |
Why?
|
| Sodium Chloride | 1 | 1980 | 584 | 0.000 |
Why?
|
| Mitosis | 1 | 1983 | 1178 | 0.000 |
Why?
|
| Antigens, Surface | 1 | 1982 | 1617 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1983 | 1441 | 0.000 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1980 | 5703 | 0.000 |
Why?
|